Litcius/Paper detail

Effects of Sacubitril/Valsartan in Patients with High Arrhythmic Risk and an ICD: A Longitudinal Study

Matteo Casale, Michele Correale, Giulia Laterra, Vittoria Vaccaro, Claudia Morabito, Pasquale Crea, Salvatore Santo Signorelli, Niki Katsiki, Francesco Luzza, Cesare de Gregorio, Giuseppe Dattilo

2021Clinical Drug Investigation24 citationsDOI

Topics & Concepts

MedicineSacubitril, ValsartanInternal medicineEjection fractionSacubitrilValsartanCardiologyHeart failureImplantable cardioverter-defibrillatorQuality of life (healthcare)Natriuretic peptideCardiac resynchronization therapyBlood pressureNursingCardiac pacing and defibrillation studiesCardiovascular Function and Risk FactorsHeart Failure Treatment and Management
Effects of Sacubitril/Valsartan in Patients with High Arrhythmic Risk and an ICD: A Longitudinal Study | Litcius